HEAD & NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD & NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD & NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop Cancer's return after surgery
Disease control Not yet recruitingThis study is testing a new treatment plan for people with high-risk head and neck cancer who have had surgery but cannot take the standard chemotherapy drug cisplatin. It will compare standard radiation therapy to radiation combined with two other drugs (nimotuzumab and bemcenti…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Apr 04, 2026 08:52 UTC
-
New scan aims to solve Post-Radiation puzzle: cancer or just inflammation?
Diagnosis Not yet recruitingThis study is testing a new, detailed type of PET scan to see if it can better tell whether tissue changes after radiation treatment for head and neck cancer are leftover cancer or just harmless inflammation. It will involve 180 adults who have finished their radiation treatment.…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC